Universal Scientific Industrial (Shanghai) (601231) Fundamentals 2026 — P/E 27.7x, Revenue Analysis | SniperIQ
Universal Scientific Industrial (Shanghai) (601231) is a CN-listed Technology company in Hardware, Equipment & Parts with a market capitalization of ¥57.9B, trading at ¥24.39 on the SHH. This SniperIQ fundamentals page covers Universal Scientific Industrial (Shanghai)'s valuation (P/E 27.7x, P/B 2.4x), profitability (net margin 3.3%), revenue (¥59.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Universal Scientific Industrial (Shanghai)'s market cap?
Universal Scientific Industrial (Shanghai) (601231) has a market capitalization of approximately ¥57.9B, trading at ¥24.39 on the SHH. Market cap moves with the live share price.
What is Universal Scientific Industrial (Shanghai)'s P/E ratio?
Universal Scientific Industrial (Shanghai)'s trailing twelve-month P/E ratio is 27.7x, with a price-to-book (P/B) of 2.4x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.
How profitable is Universal Scientific Industrial (Shanghai)?
Universal Scientific Industrial (Shanghai) runs a net profit margin of 3.3%, a gross margin of 9.5%, and an operating margin of 3.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Universal Scientific Industrial (Shanghai) generate?
Universal Scientific Industrial (Shanghai) reported revenue of ¥59.2B for fiscal year 2025, with net income of ¥1.9B and earnings per share (EPS) of 0.85. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Universal Scientific Industrial (Shanghai) pay a dividend?
Universal Scientific Industrial (Shanghai) offers a trailing dividend yield of about 1.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Universal Scientific Industrial (Shanghai) financially healthy?
Universal Scientific Industrial (Shanghai) carries a debt-to-equity ratio of 0.18x and a current ratio of 1.93x, with a market beta of 1.10. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Universal Scientific Industrial (Shanghai) a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Universal Scientific Industrial (Shanghai) (601231) the key facts are: market cap ¥57.9B, P/E 27.7x, revenue ¥59.2B, 52-week range 14.43-49.38. Weigh valuation, profitability, growth, and balance-sheet strength against Technology peers and form your own view.
Track Universal Scientific Industrial (Shanghai)'s full fundamentals live
Get Universal Scientific Industrial (Shanghai)'s 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.